Related Experiment Video

Updated: Jul 20, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Feasibility test of a shared care network for children with type 1 diabetes mellitus

Elaine Boswell King1, Rebecca Pratt Gregory1, Mary Ellen Flannery1

  • 1Vanderbilt Diabetes Research and Training Center, Nashville, Tennessee

The Diabetes Educator
|September 15, 2006
PubMed

Insights

This study found that shared care between primary care pediatricians and diabetes specialty teams is feasible for managing type 1 diabetes in children. Both families and doctors reported high satisfaction with this integrated approach.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Healthcare Delivery Models

Background:

  • Type 1 diabetes management in children requires specialized care.
  • Integrating primary care pediatricians with diabetes specialty teams can improve access and care coordination.

Purpose of the Study:

  • To assess the feasibility of a structured network for shared care of children with type 1 diabetes.
  • To evaluate the satisfaction of families and pediatricians involved in this shared care model.

Main Methods:

  • A diabetes specialty team and pediatric practice groups collaborated in a shared care network.
  • The specialty team initiated therapy and training; pediatricians provided maintenance.
  • Patient satisfaction, pediatrician satisfaction, and A1C levels were assessed.

Main Results:

  • High satisfaction reported by families and participating pediatricians.
  • Most enrolled patients completed at least one year in the network.
  • Mean A1C levels were near target in the first year, rising in the second.

Conclusions:

  • Shared care between pediatricians and diabetes specialty teams is feasible for pediatric type 1 diabetes.
  • Further research is warranted to determine the efficacy and effectiveness of this model.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...